LHX9
LIM/homeobox protein Lhx9
Also known as: LHX9_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NQ69
- Gene
- LHX9
- Ensembl
- ENSG00000143355
- Chromosome
- 1
- Canonical length
- 397 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the LIM homeobox gene family of developmentally expressed transcription factors. The encoded protein contains a homeodomain and two cysteine-rich zinc-binding LIM domains involved in protein-protein interactions. The protein is highly similar to a mouse protein that causes gonadal agenesis when inactivated, suggesting a role in gonadal development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
397 residues, UniProt reviewed canonical sequence.
>Q9NQ69|LHX9
1 MEIVGCRAED NSCPFRPPAM LFHGISGGHI QGIMEEMERR SKTEARLAKG AQLNGRDAGM
61 PPLSPEKPAL CAGCGGKISD RYYLLAVDKQ WHLRCLKCCE CKLALESELT CFAKDGSIYC
121 KEDYYRRFSV QRCARCHLGI SASEMVMRAR DSVYHLSCFT CSTCNKTLTT GDHFGMKDSL
181 VYCRAHFETL LQGEYPPQLS YTELAAKSGG LALPYFNGTG TVQKGRPRKR KSPALGVDIV
241 NYNSGCNENE ADHLDRDQQP YPPSQKTKRM RTSFKHHQLR TMKSYFAINH NPDAKDLKQL
301 AQKTGLTKRV LQVWFQNARA KFRRNLLRQE NGGVDKADGT SLPAPPSADS GALTPPGTAT
361 TLTDLTNPTI TVVTSVTSNM DSHESGSPSQ TTLTNLFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LHX9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- ovary: 18 nTPM
- retina: 3.5 nTPM
- testis: 2.1 nTPM
- lung: 1.3 nTPM
- hypothalamus: 1.1 nTPM
- blood vessel: 0.7 nTPM
Single-cell type
- leydig cells: 137 nCPM
- peritubular myoid cells: 62 nCPM
- retinal amacrine cells: 61 nCPM
- ovarian stromal cells: 19 nCPM
- ependymal cells: 14 nCPM
- brain excitatory neurons: 6.7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 36 nTPM
- thalamus: 34 nTPM
- hypothalamus: 8.9 nTPM
- pons: 7 nTPM
- amygdala: 5.7 nTPM
- medulla oblongata: 3.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LHX9.
Disease | ImmuneIEDB
Conditions an epitope on LHX9 was assayed in.
- narcolepsy T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 1.08
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell population proliferation
- female gonad development
- male gonad development
- negative regulation of DNA-templated transcription
- neuron differentiation
- regulation of transcription by RNA polymerase II
- dorsal spinal cord interneuron anterior axon guidance
- gonad morphogenesis
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- metal ion binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LHX9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LHX9 as an antibody target. Whether an autoantibody or antibody against LHX9 could matter depends on whether native LHX9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LHX9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LHX9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...